Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Cholestatic Pruritus- Pipeline Insight, 2024
Cholestatic Pruritus- Pipeline Insight, 2024 DelveInsight’s, “Cholestatic Pruritus- Pipeline Insight, 2024,” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Cholestatic Pruritus pipeline landscape. It covers the pipeline drug profiles, including clinical and noncli ... Read More
-
Choroideremia - Pipeline Insight, 2024
Choroideremia - Pipeline Insight, 2024 DelveInsight’s, Choroideremia - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Choroideremia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More
-
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis C Virus Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic Hepatitis C Virus Infection pipeline landscape. It covers the pipel ... Read More
-
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024 DelveInsight’s, “Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Hepatitis Delta Virus (HDV) Infection pipeline ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy- Pipeline Insight, 2024
Chronic Inflammatory Demyelinating Polyneuropathy- Pipeline Insight, 2024 DelveInsight’s, “Chronic Inflammatory Demyelinating Polyneuropathy- Pipeline Insight, 2024” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Chronic Inflammatory Demyelinating Polyneuropathy ... Read More
-
Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034
Sjogren's Syndrome - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The prevalence of pulmonary arterial hypertension has been increasing due to the rising frequency of cardiovascular diseases and arterial hypertension. Furthermore, the growing adult population, which is more ... Read More
-
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights Attributed to the rising diagnosed prevalent cases and increasing awareness, the Molybdenum Cofactor Deficiency Type A (MoCoD-A) market was valued at nearly USD 12 million in 2023 and is expected to exp ... Read More
-
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034
Myasthenia Gravis - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In the last few years, immunotherapy has undergone a new phase of ... Read More
-
Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2034
Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Myasthenia Gravis market is projected to witness consistent growth throughout the forecast period (2024–2034). The market size of Myasthenia gravis in the 7MM is expected to increase, driven by the launch ... Read More
-
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2024
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2024 “Adenosine A2 Receptor Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2 Receptor Antagonist developmen ... Read More
-
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2024
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2024 “Adenosine A2A Receptor Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Antagonist develop ... Read More
-
Adrenergic Antagonist - Pipeline Insight, 2024
Adrenergic Antagonist - Pipeline Insight, 2024 “Adrenergic Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adrenergic Antagonist development. The report provides detailed c ... Read More
-
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024 Adult T-Cell Leukemia-Lymphoma Overview ""Adult T-Cell Leukemia-Lymphoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Adult T-Cell Leukem ... Read More
-
Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024
Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024 Advanced Breast Cancer in Premenopausal Women Overview ""Advanced Breast Cancer in Premenopausal Women Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and gr ... Read More
-
Advanced Heart Failure - Pipeline Insight, 2024
Advanced Heart Failure - Pipeline Insight, 2024 Advanced Heart Failure Overview ""Advanced Heart Failure Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Advanced Heart Failure market. A detailed p ... Read More
-
Advanced Pancreatic Cancer - Pipeline Insight, 2024
Advanced Pancreatic Cancer - Pipeline Insight, 2024 Advanced Pancreatic Cancer Overview ""Advanced Pancreatic Cancer Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Advanced Pancreatic Cancer mark ... Read More
-
Age-related Macular Degeneration (AMD) - Pipeline Insight, 2024
Age-related Macular Degeneration (AMD) - Pipeline Insight, 2024 Age-related Macular Degeneration (AMD) Overview ""Age-related Macular Degeneration (AMD) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across ... Read More
-
Alcohol Addiction - Pipeline Insight, 2024
Alcohol Addiction - Pipeline Insight, 2024 Alcohol Addiction Overview ""Alcohol Addiction Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Alcohol Addiction market. A detailed picture of the Alcoho ... Read More
-
Alcoholic steatohepatitis - Pipeline Insight, 2024
Alcoholic steatohepatitis - Pipeline Insight, 2024 Alcoholic steatohepatitis Overview ""Alcoholic steatohepatitis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Alcoholic steatohepatitis market. ... Read More
-
Klebsiella Pneumoniae Infections - Pipeline Insight, 2024
Klebsiella Pneumoniae Infections - Pipeline Insight, 2024 DelveInsight’s, Klebsiella Pneumoniae Infections - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Klebsiella Pneumoniae Infections pipeline landscape. It covers the pipeline drug pr ... Read More
-
Allogenic Cell Therapies - Pipeline Insight, 2024
Allogenic Cell Therapies - Pipeline Insight, 2024 Allogenic Cell Therapies Overview ""Allogenic Cell Therapies Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allogenic Cell Therapies market. A de ... Read More
-
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2024
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2024 “Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects ac ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024 “Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 7 (A4b7) Int ... Read More
-
Alpha-1 Protease Inhibitor Deficiency - Pipeline Insight, 2024
Alpha-1 Protease Inhibitor Deficiency - Pipeline Insight, 2024 Alpha-1 Protease Inhibitor Deficiency Overview ""Alpha-1 Protease Inhibitor Deficiency Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ... Read More
-
Alpha-Amylase Inhibitor - Pipeline Insight, 2024
Alpha-Amylase Inhibitor - Pipeline Insight, 2024 “Alpha-Amylase Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-Amylase Inhibitor development. The report provides deta ... Read More
Research Assistance
